Prof Steven Tong
Clinical Professorial Fellow
Department of Infectious Diseases
496 Scholarly works
48 Projects
HIGHLIGHTS
2026
Journal article
Communicable episode 45: top infectious diseases papers in 2025
DOI: 10.1016/j.cmicom.2026.1052032026
Journal article
Benzylpenicillin versus flucloxacillin or cloxacillin for the treatment of penicillin-susceptible Staphylococcus aureus bacteraemia (SNAP): an international, multicentre, open-label, non-inferiority randomised controlled trial
DOI: 10.1016/S0140-6736(26)00761-02026
Journal article
Flucloxacillin plasma and urinary concentrations with and without probenecid and urinary biomarker profiles in healthy volunteers.
DOI: 10.1002/bcp.706632026
Journal article
An Achilles' heel for methicillin-resistant Staphylococcus aureus? Re-evaluating β-lactam susceptibility of MRSA.
DOI: 10.1128/aac.00374-262025
Research grants (ARC, NHMRC, MRFF)
The Staphylococcus Aureus Network Adaptive Platform (SNAP) Trial
2025
Research grants (ARC, NHMRC, MRFF)
Promoat: An Adaptive Platform Trial of Antibiotic Therapy to Improve Outcomes From Preterm Prelabour Rupture of Membranes
2020
Research grants (ARC, NHMRC, MRFF)
The Staphylococcus Aureus Network Adaptive Platform Trial
RECENT SCHOLARLY WORKS
2026
Journal article
Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.
DOI: 10.1093/cid/ciag3872026
Journal article
Towards use of Patient-informed Relevant Outcomes (PRO) in trials of bloodstream infections: a mixed-methods study protocol (BALANCE PRO).
DOI: 10.1136/bmjopen-2026-1198492026
Journal article
A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.
DOI: 10.1093/jac/dkag2152026
Journal article
Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population
DOI: 10.5694/mja2.702412026
Journal article
Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).
DOI: 10.1097/CCM.00000000000071342026
Journal article
Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
DOI: 10.1056/NEJMoa2506905
RECENT PROJECTS
2025
Research grants (ARC, NHMRC, MRFF)
STReptococcal Adaptive Platform Trial (STRAP)
2024
Research grants (ARC, NHMRC, MRFF)
Laboratory Detection and Clinical Significance of the Cefazolin Inoculum Effect for Staphylococcus Aureus Bloodstream Infections